• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿肯色州 COVID-19 大流行第一年的儿科 SARS-CoV-2 血清流行率。

Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic.

机构信息

Department of Microbiology & Immunology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

Center for Microbial Pathogenesis and Host Inflammatory Responses, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

出版信息

J Pediatric Infect Dis Soc. 2022 Jun 22;11(6):248-256. doi: 10.1093/jpids/piac010.

DOI:10.1093/jpids/piac010
PMID:35294550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8992271/
Abstract

BACKGROUND

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) seroprevalence studies largely focus on adults, but little is known about spread in children. We determined SARS-CoV-2 seroprevalence in children and adolescents from Arkansas over the first year of the coronavirus disease of 2019 (COVID-19) pandemic.

METHODS

We tested remnant serum samples from children ages 1-18 years who visited Arkansas hospitals or clinics for non-COVID-19-related reasons from April 2020 through April 2021 for SARS-CoV-2 antibodies. We used univariable and multivariable regression models to determine the association between seropositivity and participant characteristics.

RESULTS

Among 2357 participants, seroprevalence rose from 7.9% in April/May 2020 (95% CI, 4.9-10.9) to 25.0% in April 2021 (95% CI, 21.5-28.5). Hispanic and black children had a higher association with antibody positivity than non-Hispanic and white children, respectively, in multiple sampling periods.

CONCLUSIONS

By spring 2021, most children in Arkansas were not infected with SARS-CoV-2. With the emergence of SARS-CoV-2 variants, recognition of long-term effects of COVID-19, and the lack of an authorized pediatric SARS-CoV-2 vaccine at the time, these results highlight the importance of including children in SARS-CoV-2 public health, clinical care, and research strategies.

摘要

背景

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)血清流行率研究主要集中在成年人,但对儿童中的传播情况知之甚少。我们在 2019 年冠状病毒病(COVID-19)大流行的第一年,确定了阿肯色州儿童和青少年中的 SARS-CoV-2 血清流行率。

方法

我们检测了 2020 年 4 月至 2021 年 4 月期间因非 COVID-19 相关原因而到阿肯色州医院或诊所就诊的 1-18 岁儿童的剩余血清样本中的 SARS-CoV-2 抗体。我们使用单变量和多变量回归模型来确定血清阳性率与参与者特征之间的关联。

结果

在 2357 名参与者中,血清阳性率从 2020 年 4/5 月的 7.9%(95%CI,4.9-10.9)上升到 2021 年 4 月的 25.0%(95%CI,21.5-28.5)。在多个采样期内,与非西班牙裔和白人儿童相比,西班牙裔和黑人儿童的抗体阳性率更高。

结论

到 2021 年春季,阿肯色州的大多数儿童并未感染 SARS-CoV-2。随着 SARS-CoV-2 变异株的出现、对 COVID-19 长期影响的认识以及当时缺乏授权的儿童 SARS-CoV-2 疫苗,这些结果强调了将儿童纳入 SARS-CoV-2 公共卫生、临床护理和研究策略的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77e2/9214783/6621565d9e7a/piac010_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77e2/9214783/bf7b3cb6e536/piac010_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77e2/9214783/6621565d9e7a/piac010_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77e2/9214783/bf7b3cb6e536/piac010_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77e2/9214783/6621565d9e7a/piac010_fig2.jpg

相似文献

1
Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic.阿肯色州 COVID-19 大流行第一年的儿科 SARS-CoV-2 血清流行率。
J Pediatric Infect Dis Soc. 2022 Jun 22;11(6):248-256. doi: 10.1093/jpids/piac010.
2
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.加拿大艾伯塔省 COVID-19 大流行前两波期间 SARS-CoV-2 抗体的预疫苗阳性率。
Microbiol Spectr. 2021 Sep 3;9(1):e0029121. doi: 10.1128/Spectrum.00291-21. Epub 2021 Aug 18.
3
The Seroprevalence of SARS-CoV-2 in Children During Early COVID-19 Pandemic in Korea: A Nationwide, Population-Based Study.韩国 COVID-19 大流行早期儿童中 SARS-CoV-2 的血清流行率:一项全国性、基于人群的研究。
J Korean Med Sci. 2022 Nov 14;37(44):e314. doi: 10.3346/jkms.2022.37.e314.
4
A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States.美国儿童和青少年中 SARS-CoV-2 血清流行率及相关危险因素的横断面研究。
PLoS One. 2021 Nov 8;16(11):e0259823. doi: 10.1371/journal.pone.0259823. eCollection 2021.
5
Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.印度马哈拉施特拉邦西部地区农村人群中 SARS-CoV-2 特异性免疫球蛋白 G 抗体的血清流行率。
J Glob Health. 2023 Apr 21;13:06011. doi: 10.7189/jogh.13.06011.
6
The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional study.澳大利亚儿童中 SARS-CoV-2 特异性抗体的血清流行率:一项横断面研究。
PLoS One. 2024 Sep 18;19(9):e0300555. doi: 10.1371/journal.pone.0300555. eCollection 2024.
7
Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.苏格兰对 COVID-19 的强化监测:在疫情第一波期间对 SARS-CoV-2 进行基于人群的血清流行率监测。
Public Health. 2021 Jan;190:132-134. doi: 10.1016/j.puhe.2020.11.014. Epub 2020 Nov 24.
8
Seroprevalence of anti-SARS-CoV-2 antibodies among children and their parents in Greece.希腊儿童及其父母的抗 SARS-CoV-2 抗体血清阳性率。
Eur J Pediatr. 2023 Jan;182(1):439-449. doi: 10.1007/s00431-022-04681-8. Epub 2022 Nov 16.
9
SARS-CoV-2 seroprevalence among children in Latvia: A cross-sectional study.拉脱维亚儿童中 SARS-CoV-2 血清流行率:一项横断面研究。
Medicine (Baltimore). 2023 Feb 10;102(6):e32795. doi: 10.1097/MD.0000000000032795.
10
Temporal Variations in Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Infections by Race and Ethnicity in Arkansas.阿肯色州不同种族和族裔严重急性呼吸综合征冠状病毒2感染血清阳性率的时间变化
Open Forum Infect Dis. 2022 Mar 23;9(5):ofac154. doi: 10.1093/ofid/ofac154. eCollection 2022 May.

引用本文的文献

1
Seroprevalence of SARS-CoV-2 IgG antibodies in children seeking medical care in Seattle, WA June 2020 to December 2022.2020年6月至2022年12月在华盛顿州西雅图寻求医疗护理的儿童中SARS-CoV-2 IgG抗体的血清流行率。
Microbiol Spectr. 2025 Apr;13(4):e0262524. doi: 10.1128/spectrum.02625-24. Epub 2025 Mar 10.
2
Analytical measuring interval, linearity, and precision of serology assays for detection of SARS-CoV-2 antibodies according to CLSI guidelines.根据 CLSI 指南,分析测量区间、血清学检测方法的线性度和精密度与 SARS-CoV-2 抗体检测。
mSphere. 2024 Nov 21;9(11):e0039324. doi: 10.1128/msphere.00393-24. Epub 2024 Oct 31.
3

本文引用的文献

1
Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study).与 COVID-19 相关的危重症患儿多系统炎症综合征(MIS-C)的死亡率和临床特征:一项观察性多中心研究(MISCO 研究)。
BMC Pediatr. 2021 Nov 18;21(1):516. doi: 10.1186/s12887-021-02974-9.
2
Demographic and Clinical Factors Associated With Death Among Persons <21 Years Old With Multisystem Inflammatory Syndrome in Children-United States, February 2020-March 2021.2020年2月至2021年3月美国21岁以下儿童多系统炎症综合征患者中与死亡相关的人口统计学和临床因素
Open Forum Infect Dis. 2021 Jul 19;8(8):ofab388. doi: 10.1093/ofid/ofab388. eCollection 2021 Aug.
3
Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections.
年龄较小的儿童和农村儿童因感染新冠病毒而住院的可能性更大。
PLoS One. 2024 Oct 2;19(10):e0308221. doi: 10.1371/journal.pone.0308221. eCollection 2024.
4
Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario.安大略省多伦多市接受初级护理的儿童中SARS-CoV-2抗体的血清流行率。
Can J Public Health. 2024 Dec;115(6):913-923. doi: 10.17269/s41997-024-00916-3. Epub 2024 Aug 21.
5
Factors associated with SARS-CoV-2 infection in unvaccinated children and young adults.与未接种疫苗的儿童和青少年感染 SARS-CoV-2 相关的因素。
BMC Infect Dis. 2024 Jan 15;24(1):91. doi: 10.1186/s12879-023-08950-1.
6
Rural Research Network to engage rural and minority community members in translational research.农村研究网络让农村和少数族裔社区成员参与转化研究。
J Clin Transl Res. 2023 Mar 28;9(2):115-122. eCollection 2023 Apr 28.
7
Comparison of the prevalence of SARS-CoV-2 nucleoprotein antibodies in healthcare workers and an unselected adult and paediatric all-comer patient population: insights from a longitudinal study of healthcare workers and concurrent serial cross-sectional studies of patients at an academic medical centre in Austria.比较 SARS-CoV-2 核衣壳蛋白抗体在医护人员和未经选择的成年和儿科所有患者人群中的流行率:来自奥地利一所学术医学中心对医护人员进行的纵向研究和对患者进行的同期系列横断面研究的结果。
BMJ Open. 2023 Jan 18;13(1):e063760. doi: 10.1136/bmjopen-2022-063760.
8
Infection-induced immunity is associated with protection against SARS-CoV-2 infection, but not decreased infectivity during household transmission.感染诱导的免疫与预防新冠病毒感染有关,但与家庭传播期间传染性降低无关。
medRxiv. 2022 Oct 11:2022.10.10.22280915. doi: 10.1101/2022.10.10.22280915.
9
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization.COVID-19 的血清学科学网络(SeroNet):血清学检测的深度和广度,以及检测协调计划。
mSphere. 2022 Aug 31;7(4):e0019322. doi: 10.1128/msphere.00193-22. Epub 2022 Jun 15.
10
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021.2020 年 6 月至 2021 年 5 月德国儿童中 SARS-CoV-2 抗体的横断面血清流行率调查。
Nat Commun. 2022 Jun 6;13(1):3128. doi: 10.1038/s41467-022-30482-6.
SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility - Oklahoma, April-May 2021.SARS-CoV-2 B.1.617.2(德尔塔)变异株引发的新冠肺炎疫情与一家体操馆相关- 2021 年 4 月-5 月,美国俄克拉荷马州。
MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):1004-1007. doi: 10.15585/mmwr.mm7028e2.
4
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.COVID-19 mRNA 疫苗诱导针对三种 SARS-CoV-2 变体的抗体反应。
Nat Commun. 2021 Jun 28;12(1):3991. doi: 10.1038/s41467-021-24285-4.
5
Stressful life events and social capital during the early phase of COVID-19 in the U.S.美国新冠疫情早期阶段的生活应激事件与社会资本
Soc Sci Humanit Open. 2020;2(1):100057. doi: 10.1016/j.ssaho.2020.100057. Epub 2020 Aug 28.
6
Hospitalization of Adolescents Aged 12-17 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1, 2020-April 24, 2021.12-17 岁青少年因实验室确诊 COVID-19 住院情况 - COVID-NET,14 个州,2020 年 3 月 1 日-2021 年 4 月 24 日。
MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):851-857. doi: 10.15585/mmwr.mm7023e1.
7
A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States.美国基于人群的新冠病毒抗体血清阳性寿命分析。
EClinicalMedicine. 2021 Jun;36:100902. doi: 10.1016/j.eclinm.2021.100902. Epub 2021 May 24.
8
IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays.用多重免疫印迹分析法定性检测 COVID-19 中刺突蛋白和核衣壳蛋白的 IgG 和 IgM 抗体形成。
BMC Infect Dis. 2021 Apr 7;21(1):325. doi: 10.1186/s12879-021-06031-9.
9
Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years - Mississippi, May-September 2020.2020年5月至9月密西西比州18岁以下人群中估计的严重急性呼吸综合征冠状病毒2血清流行率
MMWR Morb Mortal Wkly Rep. 2021 Mar 5;70(9):312-315. doi: 10.15585/mmwr.mm7009a4.
10
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗策略:对3期候选疫苗的全面综述
NPJ Vaccines. 2021 Feb 22;6(1):28. doi: 10.1038/s41541-021-00292-w.